Bank of America’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$42M Sell
2,426,628
-704,808
-23% -$12.2M ﹤0.01% 1628
2025
Q1
$68.5M Buy
3,131,436
+1,451,223
+86% +$31.7M 0.01% 1198
2024
Q4
$53.6M Buy
1,680,213
+705,209
+72% +$22.5M ﹤0.01% 1243
2024
Q3
$28.1M Sell
975,004
-20,065
-2% -$579K ﹤0.01% 1804
2024
Q2
$38.2M Buy
995,069
+271,625
+38% +$10.4M ﹤0.01% 1468
2024
Q1
$42.5M Buy
723,444
+289,107
+67% +$17M ﹤0.01% 1395
2023
Q4
$26M Sell
434,337
-270,618
-38% -$16.2M ﹤0.01% 1604
2023
Q3
$26.8M Buy
704,955
+295,113
+72% +$11.2M ﹤0.01% 1521
2023
Q2
$37.3M Sell
409,842
-197,893
-33% -$18M ﹤0.01% 1328
2023
Q1
$40.1M Buy
607,735
+138,723
+30% +$9.15M ﹤0.01% 1353
2022
Q4
$24.3M Sell
469,012
-222,865
-32% -$11.5M ﹤0.01% 1594
2022
Q3
$47.3M Buy
691,877
+323,561
+88% +$22.1M 0.01% 1152
2022
Q2
$16.7M Sell
368,316
-13,642
-4% -$617K ﹤0.01% 1894
2022
Q1
$19.4M Buy
381,958
+107,052
+39% +$5.44M ﹤0.01% 1901
2021
Q4
$13M Sell
274,906
-5,066
-2% -$240K ﹤0.01% 2291
2021
Q3
$9.23M Buy
279,972
+39,593
+16% +$1.31M ﹤0.01% 2547
2021
Q2
$15.2M Sell
240,379
-117,600
-33% -$7.43M ﹤0.01% 2107
2021
Q1
$15.4M Buy
357,979
+206,354
+136% +$8.85M ﹤0.01% 2046
2020
Q4
$8.67M Buy
151,625
+27,681
+22% +$1.58M ﹤0.01% 2273
2020
Q3
$3.74M Sell
123,944
-54,697
-31% -$1.65M ﹤0.01% 2784
2020
Q2
$5.84M Sell
178,641
-34,479
-16% -$1.13M ﹤0.01% 2422
2020
Q1
$5.71M Buy
213,120
+18,219
+9% +$488K ﹤0.01% 2264
2019
Q4
$5.97M Buy
194,901
+45,710
+31% +$1.4M ﹤0.01% 2628
2019
Q3
$3.59M Sell
149,191
-52,079
-26% -$1.25M ﹤0.01% 2998
2019
Q2
$5.1M Buy
201,270
+8,643
+4% +$219K ﹤0.01% 2755
2019
Q1
$3.76M Buy
192,627
+175,094
+999% +$3.42M ﹤0.01% 2977
2018
Q4
$231K Buy
17,533
+10,407
+146% +$137K ﹤0.01% 4723
2018
Q3
$126K Sell
7,126
-14,021
-66% -$248K ﹤0.01% 5041
2018
Q2
$465K Buy
21,147
+20,097
+1,914% +$442K ﹤0.01% 4280
2018
Q1
$23K Sell
1,050
-330
-24% -$7.23K ﹤0.01% 5588
2017
Q4
$30K Buy
+1,380
New +$30K ﹤0.01% 5468